SpringWorks Therapeutics, Inc.
General ticker "SWTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.9B (TTM average)
SpringWorks Therapeutics, Inc. follows the US Stock Market performance with the rate: 26.9%.
Estimated limits based on current volatility of 0.1%: low 46.97$, high 47.03$
Factors to consider:
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [18.87$, 43.45$]
- 2025-12-31 to 2026-12-31 estimated range: [11.79$, 29.18$]
Financial Metrics affecting the SWTX estimates:
- Negative: Non-GAAP EPS, $ of -3.48 <= 0.05
- Negative: Operating cash flow per share per price, % of -5.67 <= 1.99
- Negative: negative Net income
- Negative: Operating profit margin, % of -59.21 <= 0.04
- Negative: Inventory ratio change, % of 21.11 > 0.93
- Negative: Industry earnings per price (median), % of -24.73 <= 0
- Negative: Industry operating profit margin (median), % of -98.39 <= 0.07
Short-term SWTX quotes
Long-term SWTX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $5.45MM | $191.59MM |
| Operating Expenses | $280.67MM | $348.46MM | $469.72MM |
| Operating Income | $-280.67MM | $-343.01MM | $-278.13MM |
| Non-Operating Income | $3.26MM | $17.91MM | $20.00MM |
| R&D Expense | $146.12MM | $150.49MM | $200.52MM |
| Income(Loss) | $-277.42MM | $-325.10MM | $-258.13MM |
| Profit(Loss)* | $-274.16MM | $-325.10MM | $-258.13MM |
| Stockholders Equity | $558.19MM | $626.22MM | $481.10MM |
| Inventory | $0.00MM | $3.10MM | $10.21MM |
| Assets | $630.24MM | $725.79MM | $587.28MM |
| Operating Cash Flow | $-161.56MM | $-222.79MM | $-175.60MM |
| Capital expenditure | $10.20MM | $7.38MM | $4.45MM |
| Investing Cash Flow | $-215.60MM | $34.75MM | $64.55MM |
| Financing Cash Flow | $340.70MM | $296.64MM | $4.76MM |
| Earnings Per Share** | $-5.14 | $-5.15 | $-3.48 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.